Business · 05/07/2002Updated: 10/17/2026 · 1 min read
FDA Issues New Export Requirements for Investigational New Drugs
The U.S. Food and Drug Administration (FDA) has announced new export requirements for unapproved new drug products, including investigational new drugs, to ensure compliance with export regulations and prevent the diversion of controlled substances.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →